Another shareholder filed suit against medical device company Abiomed (NSDQ:ABMD), alleging that the heart pump maker and its management deliberately concealed allegedly illegal marketing practices for its Impella 2.5 device that led to a U.S. Justice Dept. probe.
Abiomed
Abiomed slides on lower Q3 profits
Abiomed (NSDQ:ABMD) shares dipped sharply this morning after the medical device company reported lower profits during its fiscal 3rd quarter, despite posting strong sales growth.
Danvers, Mass.-based Abiomed logged profits of $2.7 million, or 7¢ per share, on sales of $38.3 million for the 3 months ended Dec. 31, 2012, for a profit decline of 8.1% and top-line growth of 18.8% compared with the same period in 2011.
UPDATE: Did Abiomed fly too close to the sun?
FDA panel decision means Abiomed will need new PMA for Impella pump
An FDA panel decision will require some cardiovascular pump makers to submit their already-approved medical devices for review under the FDA’s more stringent premarket review pathway.
The federal watchdog agency’s Circulatory Devices Advisory panel this week acknowledged that non-roller-type cardiopulmonary bypass blood pumps are life-supporting, but recommended against shifting them to a lower-risk category for temporary ventricular support. Panelists also suggested down-classification into Class II (special controls) for cardiopulmonary and circulatory bypass therapy.
Abiomed shares sink as FDA votes to keep Impella pump at highest risk level
Shareholders sue Abiomed over Impella claims
Mako Surgical prices $40M offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) priced a stock offering of more than 3 million shares at $13.15 apiece, raising some $40 million in total.
Abiomed wins FDA nod for Impella trial
AdvaMed launches online mentoring portal for job-seeking veterans
Medical device industry lobbying group AdvaMed this week unveiled the latest addition to its Medical Technology Veterans Program, a website dedicated to fostering the relationship between device makers and returning veterans who are looking for guidance and mentoring when entering the industry.